MICHELE RUSSELL-EINHORN will join Schulman IRB as vice president for oncology services, effective Sept. 1. Russell-Einhorn will build and lead Schulman’s Central Oncology Review division, to be launched later this year. As senior director of Dana-Farber Cancer Institute’s Office for Human Research Studies, Russell-Einhorn managed and oversaw five scientific review committees and seven institutional review...
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
